Reishi Mushroom: Benefits, Forms, Dosing, and Side Effects

Reishi Mushroom: Benefits, Forms, Dosing, and Side Effects

Last Updated:

Table of Contents

Current evidence position

Brad has not made a video on this topic; this is a summary of the evidence, not his view. A 2025 meta-analysis of 17 randomized trials in 971 people found small drops in body mass index, creatinine and heart rate and a rise in the antioxidant enzyme glutathione peroxidase with reishi, no effect on blood pressure, fasting glucose, blood lipids, inflammatory markers or liver enzymes, and very low certainty of evidence for every outcome [44]. Cochrane reviews found too little evidence to use reishi as a first-line cancer treatment, though it might be added to standard treatment, and found no support for using it to treat heart disease risk factors in type 2 diabetes [15, 24]. Reishi is generally well tolerated in trials, but rare liver injury has been linked to it, including a fatal case after a switch to reishi powder [32, 45]. Talk to your doctor before taking it if you take a blood thinner or diabetes medicines, or have liver disease or cancer [19, 32, 37, 49].

Key safety points

  • Rare liver injury has been linked to reishi, including fatal hepatitis after a switch to reishi powder, so ask your doctor first if you have liver disease [32, 45]. If you get abdominal pain [46], yellow skin or eyes, or feel very unwell while taking it, stop and see a doctor the same day, or for severe symptoms call your local emergency number (111 in NZ, 000 in Australia, 911 in the US, 999 in the UK) or go to the emergency department.
  • Reishi slowed platelet clumping in a small study of patients with atherosclerotic disease and in laboratory tests, though a trial in healthy volunteers found no effect on clotting [37, 38, 56]. If you take a blood thinner or anti-platelet medicine, ask your doctor first.
  • People who have had HMGCR immune-mediated necrotising myopathy should avoid mushroom supplements, including reishi: mushrooms naturally block the HMGCR enzyme, and mushroom supplements triggered a flare in a woman with the condition [41].
  • In people with gastrointestinal cancer, reishi spore powder raised the tumour marker CA72-4 [19, 53], which returned to normal after they stopped [19]. If you have cancer, tell your cancer team before taking reishi.
  • Reishi lowered blood glucose in a 2025 trial in type 2 diabetes [49], though other trials found no effect [12, 24]. If you take diabetes medicines, ask your doctor about closer glucose checks.
  • Side effects in trials were few and minor, such as nausea and insomnia [15].

Brad's videos on this topic

None yet.

1. Overview

Reishi (Ganoderma lucidum) is a mushroom used for thousands of years in traditional medicine; it is called reishi in Japan and lingzhi in China [3]. In traditional Chinese medicine it is used to improve health, restore vitality and prevent illness [45]. Supplements are sold for many uses, but the human trials are small and the certainty of their evidence is very low [44].

Like other fungi, reishi has a fruiting body, the visible mushroom that releases spores, and a mycelium, a network of fine threads. Supplements are made from either part, or from the spores. The name on the label may not match the species inside: in a US study, the majority (93%) of manufactured reishi products were identified as Ganoderma lingzhi, and none contained G. lucidum in the strict sense [3].

Reishi contains polysaccharides, mainly beta-glucans, and triterpenes such as the ganoderic and lucidenic acids [4, 6]. The two main groups are:

  • Polysaccharides, mostly beta-glucans. Mushroom polysaccharides have shown immune and antitumor effects in laboratory and animal studies [6, 20].
  • Triterpenes, particularly the ganoderic acids. In laboratory studies they have shown antibacterial, antiviral, antitumor, antioxidant, cholesterol-lowering and anti-platelet activity [4].

A hot-water extract of reishi fruiting bodies lowered blood sugar in mice [8], and a protein-bound polysaccharide from reishi blocked herpes viruses in cell culture [7]. Most findings like these come from cells and animals, and few have been confirmed in people.

2. Forms and Bioavailability

Types of Reishi Products

Reishi supplements come in several forms:

Dried Mushroom Powder: Ground fruiting body, sometimes with mycelium. One fibromyalgia trial gave 6 g of reishi a day [9].

Powdered Extracts: Made by extracting reishi with hot water, alcohol or both. Ganopoly, an extract of reishi's water-soluble polysaccharides, was used in several cancer trials [10, 11]. Content varies widely: when researchers measured triterpenes and polysaccharides in 19 batches of US reishi supplements, only 5 tested samples (26.3%) matched their labels [52].

Spore Products: Reishi spores have a tough outer wall. In a laboratory comparison, spores with the wall broken released much more water-soluble polysaccharide than intact spores [54].

Mushroom Blends/Complexes: Many products combine reishi with other mushrooms such as maitake (Grifola frondosa), shiitake (Lentinula edodes), lion's mane (Hericium erinaceus), and cordyceps (Cordyceps sinensis). A blend makes it hard to tell which mushroom caused an effect.

Absorption Considerations

In 12 healthy men given a single 3,000 mg dose of a reishi water extract, food slowed the absorption of ganoderic acid A without reducing the total absorbed, but it cut both the speed and the amount of ganoderic acid F absorbed [14]. Taking reishi on an empty stomach may help triterpene absorption, but this single small study needs confirming.

3. Evidence for Health Benefits

Immune Function and Cancer

Reishi has been studied most for immune function in people with cancer, almost always in small trials.

Cochrane Review of Clinical Trials: A Cochrane review of five randomized trials, updated in 2016, did not find enough evidence to justify reishi as a first-line cancer treatment, and it is uncertain whether reishi helps people live longer [15]. People given reishi with chemotherapy or radiotherapy were more likely to respond than those given chemotherapy or radiotherapy alone (RR 1.50; 95% CI 0.90 to 2.51, P = 0.02), though the review's figures conflict: the interval includes no effect. The authors judged that reishi could be an add-on to standard treatment [15]. The quality of the trials was generally poor [15].

Immune Function in Advanced Cancer (Uncontrolled): In 34 people with advanced cancer, 1800 mg of Ganopoly three times daily before meals for 12 weeks raised blood levels of IL-2, IL-6 and interferon-gamma and natural killer cell activity, and lowered IL-1 and TNF-alpha, compared with their own starting values [10]. The study had no control group, and tumour response was still being assessed when it was published [10].

Lung Cancer (Open-Label): In an open-label study of 36 people with advanced lung cancer, Ganopoly at 5.4 g/day for 12 weeks did not change average immune measures, including natural killer cell activity, in the 30 who finished, though some people responded markedly [11].

Colorectal Adenomas: In a study of people with colorectal adenomas (growths that can turn cancerous), 96 took an extract made from the culture medium of reishi mycelia (soluble in water, 1.5 g/day) for 12 months, and 102 untreated patients served as controls [16]. The number of adenomas fell by 0.42 with the extract and rose by 0.66 in controls, and their total size fell by 1.40 mm against a rise of 1.73 mm [16]. The controls were a no-treatment group picked from the clinic's other patients, not a placebo group.

Prostate Cancer (Preliminary): In an open-label study in Japan of men whose PSA rose after radical treatment for prostate cancer, 15 took a reishi product for 6 months and the others took an extract of another mushroom, Agaricus blazei [18]. No man had a fall in PSA of 50% or more, and no serious side effects occurred [18].

Tumor Marker Concern: In 5 cases of gastrointestinal cancer, the tumour marker CA72-4 rose after patients took reishi spore powder twice a day for 1 or 2 months [19]. Levels returned to normal quickly when they stopped, and their symptoms did not change [19]. Three similar cases were reported separately, and in two of them the unexplained rise led to unnecessary tests [53]. People with cancer whose care is tracked with tumour markers should tell their team if they take reishi.

Context from Other Mushroom-Derived Compounds: Some mushroom polysaccharides are used as drugs in Asia: lentinan (from shiitake), schizophyllan and PSK have become large market items in Japan [20]. In an analysis of 650 people from 5 trials in advanced gastric cancer, adding lentinan to chemotherapy prolonged survival (HR 0.80, 95% CI 0.68 to 0.95) [22], and a review of 38 trials from China found better response rates in lung cancer with lentinan plus chemotherapy [21]. Lentinan injection is an approved drug in several Asian countries [21], and these trials tested lentinan, not reishi [21, 22].

Preclinical Evidence Summary: In cell and animal studies, reishi polysaccharides and triterpenes show antitumor and immune effects [4, 6]. These results cannot be applied directly to supplement use in people.

Diabetes and Blood Sugar

Results on blood sugar are mixed.

Positive Trials: In a 2025 randomized trial in people with type 2 diabetes, fasting glucose, 2-hour glucose after meals and A1C fell with reishi and with kombucha mushroom, and the groups differed from a control group [49]. In a 12-week crossover trial in people with borderline high blood pressure or cholesterol, 1.44 g of reishi a day lowered insulin and insulin resistance compared with placebo [48].

Cochrane Review (Negative Overall Conclusion): A 2015 Cochrane review of five trials with a total of 398 participants found no clear effect on HbA1c (WMD -0.10%; 95% CI -1.05% to 0.85%) or fasting glucose, and concluded that the evidence does not support reishi for treating heart disease risk factors in type 2 diabetes [24].

Type 2 Diabetes with Metabolic Syndrome (Negative): In a double-blind trial, 84 people with type 2 diabetes and metabolic syndrome took 3 g/day of reishi, with or without Cordyceps sinensis, or placebo for 16 weeks [12]. Reishi had no effect on HbA1c, fasting glucose or any secondary outcome, and it did not raise the overall risk of side effects [12].

Weighing the Evidence: Two trials found some benefit, but the Cochrane review, the 16-week trial and the 2025 meta-analysis, which found no effect on fasting glucose, do not support reishi for blood sugar control [12, 24, 44].

Liver Health

Reishi is used traditionally for the liver, but the human evidence is thin, and reishi itself has been linked to rare liver injury [45].

Preclinical Evidence: A reishi polysaccharide reduced liver scarring in rats with blocked bile ducts [28], and reishi extracts protected the liver in mice given alcohol [27] and in rats given the chemical benzo[a]pyrene [26]. A reishi polysaccharide also sped the healing of stomach ulcers in rats [29].

Fatty Liver (Clinical Trial): In a double-blind crossover trial in 42 healthy adults, a reishi extract enriched in triterpenoids and polysaccharide peptides (one 225 mg capsule after lunch or dinner for six months) improved antioxidant measures and lowered the liver enzymes GOT and GPT (42 and 27%) [30]. On ultrasound, mild fatty liver returned to normal in people taking reishi [30].

Important Caveat: The same mushroom has been linked to rare liver injury, including a death from fulminant hepatitis (see Section 5: Safety and Side Effects) [32, 33, 45]. In trials, reishi has not raised liver enzymes [45, 47].

Fibromyalgia

A single trial has tested reishi for fibromyalgia. In 64 women with fibromyalgia, 6 g of reishi a day for 6 weeks improved aerobic endurance, lower body flexibility and speed, while carob (Ceratonia siliqua), the comparison treatment, did not [9]. One small trial cannot show that reishi treats fibromyalgia.

Gut Microbiota and Butyrate Production

Mushroom polysaccharides may act as prebiotics, feeding gut bacteria [34]. Gut bacteria make butyrate from fibre. Colon cells use it as fuel, and it may modulate immunity and inflammation and strengthen the gut barrier [36].

In Vitro Evidence: In a computer-controlled laboratory model of the colon, a mix of three mushrooms (reishi, maitake and oyster) was fed to gut bacteria from healthy adults for 72 h at three doses (0.5, 1.0 and 1.5 g/day) [36]. Butyrate-producing bacteria and butyrate rose with the dose, and at the highest dose butyrate roughly doubled compared with the control [36].

Limitations: This was a laboratory model of the colon that tested a blend, not reishi alone, and the authors said the results warrant future mechanistic research [36].

Anti-Inflammatory and Antioxidant Activity

Laboratory and animal studies report antioxidant and anti-inflammatory effects of reishi extracts and triterpenes [4, 26]. In people, results are mixed. The fatty liver trial found better antioxidant measures [30]. A 4-week placebo-controlled crossover trial in healthy adults (n 18) found no significant change in blood markers of antioxidant status, inflammation or immune status, apart from higher antioxidant capacity in urine [47]. The 2025 meta-analysis found no effect on inflammatory markers [44].

No large trial has tested reishi as an anti-inflammatory or antioxidant treatment in people.

Cardiovascular Health

In laboratory and animal studies, reishi compounds blocked cholesterol production in liver cells and lowered cholesterol in hamsters and minipigs [39], and its triterpenes show anti-platelet and blood pressure-lowering activity [4]. Human trials have not confirmed heart benefits. The 2015 Cochrane review found no significant difference in blood pressure or triglycerides [24], the 16-week trial found no change in any outcome [12], and a crossover trial found no change in blood pressure [48]. The 2025 meta-analysis found no effect on blood pressure or the lipid profile [44].

Antiviral and Antibacterial Activity

Laboratory studies report antiviral and antibacterial activity of reishi triterpenes [4], and a protein-bound polysaccharide from reishi blocked herpes simplex viruses in cell culture [7]. These are laboratory findings without established clinical relevance.

There is no established dose for reishi. Trials have used very different products and amounts; those pooled in the 2025 meta-analysis gave 200-11,200 mg/day for 1-24 weeks [44].

Doses Used in Clinical Trials

Condition Form Daily Dose Duration Reference
Immune function in advanced cancer Ganopoly polysaccharide extract 1800 mg three times daily 12 weeks [10]
Advanced lung cancer (immune measures) Ganopoly 5.4 g/day 12 weeks [11]
Colorectal adenomas Water-soluble extract of mycelium culture medium 1.5 g/day 12 months [16]
Type 2 diabetes + metabolic syndrome Reishi, with or without cordyceps 3 g/day 16 weeks [12]
Fibromyalgia Reishi 6 g per day 6 weeks [9]
Healthy adults (fatty liver measures) Triterpenoid- and polysaccharide-enriched extract 225 mg 6 months [30]
Clotting in healthy volunteers Reishi capsules 1.5 g 4 wk [38]

General Dosing Guidance

Extracts: The Ganopoly trials used 1800 mg three times daily [10], and the colorectal adenoma trial used 1.5 g/day of a mycelium culture-medium extract [16].

Enriched/specialized formulas: Much lower doses may be used when the product is concentrated in specific compounds. The fatty liver trial used one 225 mg capsule a day of a formula enriched in triterpenoids and polysaccharide peptides [30].

Important Dosing Considerations

  • No official Recommended Dietary Allowance (RDA), Adequate Intake (AI), or Tolerable Upper Intake Level (UL) has been established for reishi.
  • In one small study, food slowed or reduced the absorption of two ganoderic acids [14]. What this means for any benefit is unknown.
  • Products differ widely in what they contain (see Section 2) [52]. A polysaccharide extract delivers a very different amount of active compounds than plain mushroom powder at the same weight.
  • In the trials in the Cochrane cancer review, reishi was generally well tolerated, with a few minor side effects and no major toxicity [15]. Long-term safety data are limited.

5. Safety and Side Effects

Common Side Effects

Side effects in trials have been mild. In the Cochrane cancer review, one trial recorded minimal side effects, including nausea and insomnia [15]. In the Cochrane review of heart disease risk factors, people taking reishi for four months had slightly more adverse events than those on placebo, not statistically significant, none serious (RR 1.67 95% CI 0.86 to 3.24) [24].

Blood-Thinning Effects

Evidence on clotting is mixed. A water extract of reishi slowed platelet clumping in the test tube, and in 33 patients with atherosclerotic disease, 1 g 3 times a day for 2 weeks reduced platelet clumping [37]. In a laboratory screen of eight edible mushrooms, reishi extract also blocked platelet clumping, though it was toxic to platelets and white blood cells, and did not change clotting tests [56]. In a double-blind trial, 1.5 g a day for 4 wk did not change any clotting or platelet test in healthy volunteers (n = 20) compared with placebo (n = 20) [38]. Its triterpenes also show anti-platelet activity in laboratory studies [4]. If you take a blood thinner or an antiplatelet medicine, ask your doctor before using reishi (see Section 6: Drug Interactions). If you have surgery planned, tell your surgeon you take reishi, though the healthy-volunteer trial authors judged it unlikely to raise surgical bleeding risk in otherwise healthy people [38].

Liver Toxicity

Reishi has been linked to a handful of liver injury reports, including a death. LiverTox, the US National Institutes of Health liver injury resource, notes that reishi is well tolerated and has not raised liver enzymes in trials, but has been implicated in rare single cases of acute liver injury, though in most reports other causes were not adequately excluded [45].

Case 1 (Hong Kong): Liver toxicity linked to reishi powder was first described in a patient from Hong Kong in 2004 [31, 32].

Case 2 (Thailand, fatal): In 2005, a patient died of fulminant hepatitis linked to reishi powder [32]. Both this patient and the Hong Kong patient had taken boiled reishi without harm, and became ill after switching to the powder for 1-2 months; both had also taken other medicines [32].

Case 3 (eosinophilia): A 61-year-old man who had had surgery for rectal cancer developed multiple liver nodules, a marked rise in eosinophils (a type of white blood cell) and a slight rise in liver enzymes while taking a commercial reishi product [33]. A biopsy showed clusters of eosinophils. After he stopped reishi, his eosinophil counts and liver enzymes quickly returned to normal and the nodules disappeared [33].

Case 4 (with alcohol): A 47-year-old man developed acute hepatitis, with headache and abdominal pain, after taking reishi powder and alcohol; his symptoms and blood tests had returned to normal by two weeks [46].

The cause of reishi-linked liver injury is not known. Because one case was fatal, people with liver disease, or who take other medicines or alcohol that can affect the liver, should talk to their doctor before using reishi [32, 46]. If you develop abdominal pain, yellow skin or eyes, or feel very unwell while taking reishi, stop it and see a doctor the same day. For severe symptoms, call your local emergency number (111 in NZ, 000 in Australia, 911 in the US, 999 in the UK) or go to the emergency department.

HMGCR Immune-Mediated Necrotizing Myopathy (HMGCR IMNM)

Anyone who has had HMG-CoA reductase immune-mediated necrotizing myopathy (HMGCR IMNM) should stay away from mushroom supplements, including reishi [41].

HMGCR IMNM is a rare autoimmune muscle disease thought to be triggered by statins, which block the enzyme HMG-CoA reductase (HMGCR) [41]. Mushrooms are natural HMGCR inhibitors [41], and reishi reduced HMGCR activity in the livers of hamsters [39].

In a published case, a woman in her 30s with HMGCR IMNM, who had never taken a statin, had a clear flare of her myositis after starting mushroom supplements [41]. The authors stress strict statin avoidance for people with the condition, even when it is well controlled [41].

Interference with Diagnostic Testing

In a small study in healthy volunteers, a beta-glucan supplement (not reishi) did not cause false-positive results on the 1,3-beta-D-glucan blood test, which helps diagnose invasive fungal infections [51].

Pregnancy and Breastfeeding

There are insufficient data on the safety of reishi supplementation during pregnancy or breastfeeding. Given the lack of safety data and the potential for immune-modulating effects, reishi supplements should be avoided during pregnancy and lactation unless specifically advised by a healthcare provider.

6. Drug Interactions

Anticoagulants and Antiplatelet Agents

Reishi slowed platelet clumping in laboratory tests and in one small study of patients [37, 56], though a trial in healthy volunteers found no effect on clotting at 1.5 g a day [38]. Its triterpenes also show anti-platelet activity in the laboratory [4]. People taking warfarin, heparin, aspirin, clopidogrel, or other anticoagulant/antiplatelet medications should consult their healthcare provider before using reishi.

Antihypertensive Medications

A reishi water extract lowered blood pressure in hypertensive rats about as much as losartan [50], but trials in people have found no change in blood pressure [24, 44, 48]. If you take blood pressure medicines, check with your doctor or pharmacist before starting.

Immunosuppressant Medications

Reishi raised some immune markers, such as IL-2, interferon-gamma and natural killer cell activity, in people with advanced cancer [10]. In theory this could work against medicines that suppress the immune system, used to prevent transplant rejection or treat autoimmune conditions (e.g., cyclosporine, tacrolimus, corticosteroids, azathioprine). If you take immunosuppressants, ask your doctor first.

Chemotherapy Drugs

The Cochrane review found that reishi given with chemotherapy or radiotherapy may improve tumour response [15]. How reishi interacts with specific cancer drugs is unknown, and reishi spore powder has raised the tumour marker CA72-4 in people with gastrointestinal cancer [19, 53]. Cancer patients should consult their oncologist before using reishi.

Statin Medications

Mushrooms, including reishi, naturally inhibit HMG-CoA reductase, the enzyme that statins block [39, 41]. In theory, reishi could add to muscle side effects with a statin. This is mainly a concern for people with HMGCR IMNM (see Section 5) and may matter for others who have had muscle problems on statins.

Diabetes Medications

Reishi lowered blood glucose and A1C in one 2025 trial [49] and lowered blood sugar in mice [8], though other trials found no effect [12, 24]. If you take blood-sugar-lowering medications (metformin, sulfonylureas, insulin), check your blood glucose more closely when starting reishi.

Hepatotoxic Medications

Both patients in the first two reishi liver injury reports had also taken other medicines, and the authors urged close monitoring of reishi powder, especially with other drugs [32]. A later case followed reishi powder taken with alcohol [46]. If you take medicines that can affect the liver, tell your doctor before adding reishi.

7. Dietary Sources

Reishi mushroom (Ganoderma lucidum) is not a common dietary item in Western cuisines. It has traditionally been boiled in water rather than eaten whole [32].

Traditional Preparations

  • Reishi tea/decoction: Dried reishi slices boiled in water. This is the traditional preparation [32].
  • Soups and broths: Dried reishi added to soups during cooking. The mushroom pieces are typically removed before serving due to their tough, bitter nature.
  • Tinctures: Reishi soaked in alcohol (typically rice wine in traditional preparations) to extract triterpenes, which are less water-soluble.

Beta-Glucans in Other Mushrooms

Many edible mushrooms contain beta-glucans. Lentinan, a beta-glucan drug, comes from shiitake [20, 21], and in one trial 20 g of oyster mushroom powder supplied 8.1 g of beta-glucans [25]. The beta-glucan content measured in a mushroom product depends partly on the laboratory method used [55].

Other Dietary Sources of Beta-Glucans

Fungal beta-glucans, with 1,3 and 1,6 links, also come from baker's yeast (Saccharomyces cerevisiae) [57]. Oats and barley contain a different type, 1,3-1,4-beta-D-glucan.

8. References

[3] Loyd AL, et al. "Identifying the 'Mushroom of Immortality': Assessing the Ganoderma Species Composition in Commercial Reishi Products." Front Microbiol. 2018;9:1557. PMID: 30061872. https://doi.org/10.3389/fmicb.2018.01557

[4] Hsu CL, Yen GC. "Ganoderic Acid and Lucidenic Acid (Triterpenoid)." Enzymes. 2014;36:33-56. PMID: 27102698. https://doi.org/10.1016/B978-0-12-802215-3.00003-3

[6] Chang ST, Wasser SP. "The role of culinary-medicinal mushrooms on human welfare with a pyramid model for human health." Int J Med Mushrooms. 2012;14(2):95-134. PMID: 22506573. https://pubmed.ncbi.nlm.nih.gov/22506573/

[7] Oh KW, et al. "Antiherpetic activities of acidic protein bound polysacchride isolated from Ganoderma lucidum alone and in combinations with acyclovir and vidarabine." J Ethnopharmacol. 2000;72(1-2):221-227. PMID: 10967475. https://doi.org/10.1016/s0378-8741(00)00254-3

[8] Hikino H, et al. "Isolation and Hypoglycemic Activity of Ganoderans A and B, Glycans of Ganoderma lucidum Fruit Bodies." Planta Med. 1985;51(4):339-340. PMID: 17340529. https://doi.org/10.1055/s-2007-969507

[9] Collado Mateo D, et al. "Ganoderma lucidum improves physical fitness in women with fibromyalgia." Nutr Hosp. 2015;32(5):2126-2135. PMID: 26545669. https://doi.org/10.3305/nh.2015.32.5.9601

[10] Gao Y, et al. "Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients." Immunol Invest. 2003;32(3):201-215. PMID: 12916709. https://doi.org/10.1081/IMM-120022979

[11] Gao Y, et al. "Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer." J Med Food. 2005;8(2):159-168. PMID: 16117607. https://doi.org/10.1089/jmf.2005.8.159

[12] Klupp NL, et al. "A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome." Sci Rep. 2016;6:29540. PMID: 27511742. https://doi.org/10.1038/srep29540

[14] Teekachunhatean S, et al. "Pharmacokinetics of ganoderic acids A and F after oral administration of Ling Zhi preparation in healthy male volunteers." Evid Based Complement Alternat Med. 2012;2012:780892. PMID: 22577465. https://doi.org/10.1155/2012/780892

[15] Jin X, et al. "Ganoderma lucidum (Reishi mushroom) for cancer treatment." Cochrane Database Syst Rev. 2016;4(4):CD007731. PMID: 27045603. https://doi.org/10.1002/14651858.CD007731.pub3

[16] Oka S, et al. "A water-soluble extract from culture medium of Ganoderma lucidum mycelia suppresses the development of colorectal adenomas." Hiroshima J Med Sci. 2010;59(1):1-6. https://pubmed.ncbi.nlm.nih.gov/20518254/

[18] Yoshimura K, et al. "Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: an open-label study." Int J Urol. 2010;17(6):548-554. PMID: 20412340. https://doi.org/10.1111/j.1442-2042.2010.02528.x

[19] Yan B, et al. "Ganoderma lucidum spore induced CA72-4 elevation in gastrointestinal cancer: a five-case report." Integr Cancer Ther. 2014;13(2):161-166. PMID: 24282100. https://doi.org/10.1177/1534735413510022

[20] Ooi VE, Liu F. "Immunomodulation and anti-cancer activity of polysaccharide-protein complexes." Curr Med Chem. 2000;7(7):715-729. PMID: 10702635. https://doi.org/10.2174/0929867003374705

[21] Zhang Y, et al. "Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China." J Cancer Res Clin Oncol. 2018;144(11):2177-2186. PMID: 30043277. https://doi.org/10.1007/s00432-018-2718-1

[22] Oba K, et al. "Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer." Anticancer Res. 2009;29(7):2739-2745. https://pubmed.ncbi.nlm.nih.gov/19596954/

[24] Klupp NL, et al. "Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors." Cochrane Database Syst Rev. 2015;(2):CD007259. PMID: 25686270. https://doi.org/10.1002/14651858.CD007259.pub2

[25] Dicks L, et al. "Fortifying a meal with oyster mushroom powder beneficially affects postprandial glucagon-like peptide-1, non-esterified free fatty acids and hunger sensation in adults with impaired glucose tolerance: a double-blind randomized controlled crossover trial." Eur J Nutr. 2022;61(2):687-701. PMID: 34505919. https://doi.org/10.1007/s00394-021-02674-1

[26] Lakshmi B, et al. "Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene." J Ethnopharmacol. 2006;107(2):297-303. PMID: 16713154. https://doi.org/10.1016/j.jep.2006.03.027

[27] Shieh YH, et al. "Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice." Am J Chin Med. 2001;29(3-4):501-507. PMID: 11789593. https://doi.org/10.1142/S0192415X01000526

[28] Park EJ, et al. "Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction." Biol Pharm Bull. 1997;20(4):417-420. PMID: 9145221. https://doi.org/10.1248/bpb.20.417

[29] Gao Y, et al. "Ganoderma lucidum polysaccharide fractions accelerate healing of acetic acid-induced ulcers in rats." J Med Food. 2004;7(4):417-421. PMID: 15671683. https://doi.org/10.1089/jmf.2004.7.417

[30] Chiu HF, et al. "Triterpenoids and polysaccharide peptides-enriched Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study of its antioxidation and hepatoprotective efficacy in healthy volunteers." Pharm Biol. 2017;55(1):1041-1046. PMID: 28183232. https://doi.org/10.1080/13880209.2017.1288750

[31] Yuen MF, et al. "Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)." J Hepatol. 2004;41(4):686-687. PMID: 15464254. https://doi.org/10.1016/j.jhep.2004.06.016

[32] Wanmuang H, et al. "Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder." J Med Assoc Thai. 2007;90(1):179-181. https://pubmed.ncbi.nlm.nih.gov/17621752/

[33] Kogure T, et al. "Hypereosinophilia with Hepatic Nodule Formation Caused by Ganoderma lucidum." Intern Med. 2021;60(24):3897-3903. PMID: 34911873. https://doi.org/10.2169/internalmedicine.7431-21

[34] Friedman M. "Mushroom Polysaccharides: Chemistry and Antiobesity, Antidiabetes, Anticancer, and Antibiotic Properties in Cells, Rodents, and Humans." Foods. 2016;5(4):80. PMID: 28231175. https://doi.org/10.3390/foods5040080

[36] Verhoeven J, et al. "A blend of 3 mushrooms dose-dependently increases butyrate production by the gut microbiota." Benef Microbes. 2021;12(6):601-612. PMID: 34590532. https://doi.org/10.3920/BM2021.0015

[37] Tao J, Feng KY. "Experimental and clinical studies on inhibitory effect of ganoderma lucidum on platelet aggregation." J Tongji Med Univ. 1990;10(4):240-243. PMID: 2098581. https://pubmed.ncbi.nlm.nih.gov/2098581/

[38] Kwok Y, et al. "A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatic effects of Ganoderma lucidum (Ling-Zhi) in healthy volunteers." Anesth Analg. 2005;101(2):423-426. PMID: 16037156. https://doi.org/10.1213/01.ANE.0000155286.20467.28

[39] Berger A, et al. "Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs." Lipids Health Dis. 2004;3:2. PMID: 14969592. https://doi.org/10.1186/1476-511X-3-2

[41] Adler B, et al. "Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy." BMJ Case Rep. 2022;15(5):e248880. PMID: 35606030. https://doi.org/10.1136/bcr-2022-248880

[44] Jafari A, et al. "The Nutritional Significance of Ganoderma lucidum on Human Health: A GRADE-Assessed Systematic Review and Meta-Analysis of Clinical Trials." Food Sci Nutr. 2025;13(6):e70423. PMID: 40510787. https://doi.org/10.1002/fsn3.70423

[45] National Institute of Diabetes and Digestive and Kidney Diseases. "Lingzhi, Reishi." LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Updated 2024 Oct 5. PMID: 39527685. https://pubmed.ncbi.nlm.nih.gov/39527685/

[46] Guedikian R, et al. "Ganoderma lingzhi (Reishi Mushroom)-Induced Acute Liver Injury in the Setting of Alcohol Use: A Case Report and Review of the Literature." Cureus. 2023;15(9):e45953. PMID: 37885515. https://doi.org/10.7759/cureus.45953

[47] Wachtel-Galor S, et al. "Ganoderma lucidum ('Lingzhi'), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study." Br J Nutr. 2004;91(2):263-269. PMID: 14756912. https://doi.org/10.1079/BJN20041039

[48] Chu TT, et al. "Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial." Br J Nutr. 2012;107(7):1017-1027. PMID: 21801467. https://doi.org/10.1017/S0007114511003795

[49] Yekefallah L, et al. "Comparing the Effects of Ganoderma lucidum and Kombucha Mushrooms on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial." Clin Diabetes. 2025;43(5):813-822. PMID: 41438309. https://doi.org/10.2337/cd25-0032

[50] Shevelev OB, et al. "Hypotensive and neurometabolic effects of intragastric Reishi (Ganoderma lucidum) administration in hypertensive ISIAH rat strain." Phytomedicine. 2018;41:1-6. PMID: 29519314. https://doi.org/10.1016/j.phymed.2018.01.013

[51] Spriet I, et al. "No interference of the 1,3-beta-D-glucan containing nutritional supplement ImunixX with the 1,3-beta-D-glucan serum test." Mycoses. 2011;54(5):e352-e353. PMID: 20637053. https://doi.org/10.1111/j.1439-0507.2010.01922.x

[52] Wu DT, et al. "Evaluation on quality consistency of Ganoderma lucidum dietary supplements collected in the United States." Sci Rep. 2017;7(1):7792. PMID: 28798349. https://doi.org/10.1038/s41598-017-06336-3

[53] Liang Y, et al. "An abnormal elevation of serum CA72-4 by ganoderma lucidum spore powder." Ann Clin Lab Sci. 2013;43(3):337-340. PMID: 23884232. https://pubmed.ncbi.nlm.nih.gov/23884232/

[54] Bao XF, et al. "Studies on difference between sporoderm-broken and nonbroken spores of Ganoderma lucidum (Leyss. ex Fr.) Karst. by polysaccharide analysis." Zhongguo Zhong Yao Za Zhi. 2001;26(5):326-328. PMID: 12528523. https://pubmed.ncbi.nlm.nih.gov/12528523/

[55] McCleary BV, Draga A. "Measurement of beta-Glucan in Mushrooms and Mycelial Products." J AOAC Int. 2016;99(2):364-373. PMID: 26957216. https://doi.org/10.5740/jaoacint.15-0289

[56] Poniedziałek B, et al. "The Effect of Mushroom Extracts on Human Platelet and Blood Coagulation: In vitro Screening of Eight Edible Species." Nutrients. 2019;11(12):3040. PMID: 31842490. https://doi.org/10.3390/nu11123040

[57] Vlassopoulou M, et al. "Effects of fungal beta-glucans on health - a systematic review of randomized controlled trials." Food Funct. 2021;12(8):3366-3380. PMID: 33876798. https://doi.org/10.1039/d1fo00122a

About Dr Brad Stanfield

Dr Brad Stanfield

Dr Brad Stanfield is a General Practitioner in Auckland, New Zealand, with a strong emphasis on preventative care and patient education. Dr Stanfield is involved in clinical research, having co-authored several papers, and is a Fellow of the Royal New Zealand College of General Practitioners. He also runs a YouTube channel with over 319,000 subscribers, where he shares the latest clinical guidelines and research to promote long-term health.

YouTube LinkedIn
Back to Articles